Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicenter study

Figure 1 Detection by IIF of (A) ASCA on smears of Saccharomyces cerevisiae, (B) NANA on ethanol-fixed human neutrophils and (C) PAB on human pancreas (× 400). IIF: indirect immunofluorescence; ASCA: anti-Saccharomyces cerevisiae antibodies; NANA: anti-Nuclear Associated Neutrophil Antibodies; PAB: anti-pancreatic antibodies.

Figure 2 Detection of ASCA and NANA in CrD and UC patient groups and HBD. ASCA: anti-Saccharomyces cerevisiae antibodies; NANA: anti-Nuclear Associated Neutrophil Antibodies; CrD: Crohn’s disease; UC: ulcerative colitis; HBD: healthy blood donors.

Figure 3 Detection of ASCA and NANA in CoD. Data obtained for patients with an active (AcoD) or a remitting (RcoD) form of the disease are represented. ASCA: anti-Saccharomyces cerevisiae antibodies; NANA: anti-Nuclear associated neutrophil antibodies; CoD: coeliac disease.

Figure 4 Detection of PAB in CrD (with or without pancreatitis), UC and CoD (active or remitting form) patient groups and HBD. PAB: anti-pancreatic antibodies; CrD: Crohn’s disease; UC: ulcerative colitis; CoD: coeliac disease; HBD: healthy blood donors.